The report is an example of how BD is advancing its environmental, social & governance strategy — “Together We Advance.” It also showcases the power of diversity of thought through its 77,000 global associates.
“For 125 years, BD has delivered innovative products and solutions that have had a profound impact on global health,” Tom Polen, chairman, CEO and president of BD, said. “The diverse perspectives and experiences of our people fuels our ability to adapt to the evolving needs of patients and customers, and, as a result, ID&E is an integral part of everything we do — from setting goals to creating strategies, making decisions, ensuring accountability and empowering our associates to speak up to help create a better world and better BD.”
The report details the progress the company is making towards its 2030+ ESG goals for promoting a healthy workforce and communities. Most specifically, highlighting the improvements made to increase diverse representation by 1% year-over-year at the management and executive levels. The report also features spotlights of its global associates at various levels of the organization and Associate Resource Groups. The company continues to exceed health care industry benchmarks in gender and ethnic diversity representation.
“I am proud of the meaningful progress we are making on our journey to build a more equitable and inclusive BD,” Nicole Thompson, vice president, inclusion, diversity, equity and engagement at BD, said. “We remain committed to, and, most importantly, accountable for providing a workplace and processes that are fair and provide equal access to resources and opportunities. I am encouraged by our momentum and more committed than ever to continue delivering measurable results for our associates, customers and communities.”
As part of the company’s commitment to ID&E, it regularly participates in external benchmarking surveys to track progress and provide additional visibility to stakeholders. In 2022, BD was recognized for its inclusive policies and practices.